'The time for experimenting on patients is over': a policy scan and qualitative study of doctors' experience with the oversight of clinical innovation in Australia.

OBJECTIVES: Clinical innovation - the use outside of research of novel and unproven interventions - is subject to extensive federal and state oversight in Australia. Although the complexity of the regulatory environment is widely recognised, there ha…

Preview only. Read the full abstract at the source